(Q40209502)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Aurelia A Haller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Thomas H King

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Charles Kemmler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Valerie Fiolkoski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Yingnian Lu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Don Bellgrau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Timothy C Rodell

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

David Apelian

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Alex Franzusoff

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Richard C Duke

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

10 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1452-1463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of hepatitis C virus infection

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

American Gastroenterological Association technical review on the management of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Immunology of hepatitis B virus and hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Cell-mediated immunity and the outcome of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Toll-like receptors: critical proteins linking innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Decoding the patterns of self and nonself by the innate immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Toll-like receptors: networking for success.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Integration of Toll-like receptor and phagocytic signaling for tailored immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

The plasticity of dendritic cell responses to pathogens and their components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Activation of toll-like receptor-mediated NF-kappa beta by zymosan-derived water-soluble fraction: possible contribution of endotoxin-like substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Yeasts encoding tumour antigens in cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Vaccination of chimpanzees against infection by the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Replication of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Structural biology of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Immobilizing proteins on the surface of yeast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

A predictive model for the level of sIgA based on IgG levels following the oral administration of antigens expressed in Saccharomyces cerevisiae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.035

10.1016/J.VACCINE.2006.10.035

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17098335%20AND%20SRC:MED&resulttype=core&format=json

release_t3yhkcdrord63bfuosjv5gfj5m

21 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t3yhkcdrord63bfuosjv5gfj5m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference